Table 5.
Antibiotic | Maintenance dose | Dosing frequency | Food effect (Cmax decrease) | Protein binding | Half-life | Metabolism | Excretion |
---|---|---|---|---|---|---|---|
Tetracycline | Oral: 250/500 mg | Oral: BID to QID | 50% | 55–64% | 6–11 h | Yes | Fecal: 20–60% Renal: 30% |
Doxycycline | IV: 100 mg Oral: 100 mg |
Oral: QD or BID IV: BID |
20% | 12–25 h | Yes | Renal: 40% | |
Minocycline | IV: 100 mg Oral: 50/75/100 mg |
Oral: BID | – | 76% | 11–24 h | Yes | Fecal: 20–35% Renal: 5–12% |
Omadacycline | IV: 100 mg Oral: 300 mg |
Oral: QD IV: QD |
40–59% | 20% | 16 h | Yes | Fecal (oral): 81% Renal (IV/oral): 27%/14% |
Tigecycline | IV: 50 mg | IV: BID | NA | 71–89% | 42 h | None | Biliary/Fecal: 59% Renal: 33% |
Eravacycline | IV: 1 mg/kg | IV: BID | NA | 79–90% | 20 h | CYP3A4- and FMO-mediated oxidation | Biliary/Fecal: 47% Renal: 34% |
BID: twice daily; IV: intravenous; NA: not applicable; QD: daily; QID: four times daily.